Nelson Mandela, the world’s best known political prisoner who went on to become President of South Africa, has died at age 95.
Experts address the outbreaks of meningitis on two college campuses, with advice on how to reduce risk.
Researchers find new insight into reading disorder
Knowing how they detect skin odor might lead to better repellants, researcher says
In tiny study, 2 patients experienced a desire to conquer challenge
(Reuters) - GlaxoSmithKline and Theravance Inc said on Friday that their combination therapy met the main goal of improving lung function in asthma patients in a late-stage trial. The therapy consists of the corticosteroid, fluticasone furoate, which reduces inflammation, and a long-acting beta-agonist, called vilanterol, which is designed to open the airways. The drug, already approved in the U.S. to treat chronic obstructive pulmonary disease (COPD) under the brand name Breo, proved more effective than fluticasone furoate alone for patients with moderate to severe asthma at the end of a 12-week treatment period. It is approved for both COPD and asthma in Europe, where it is sold as Relvar.
It often feels as though time speeds up as we age, with each season and year seemingly passing by more quickly than the last. And according to some psychologists, in addition to aging, the way we interact with technology could also have a profound effect on the way we experience time. Sitting in front of computers all day, we're constantly confronted by a clock telling us what time it is, and it's no different whether we're at home or on the go: 60 percent of Gen Yers (ages 18-30) find themselves compulsively or subconsciously checking their smart phones for emails,